Markets
200Time Range
| Market | Trend | Price | 24h | Volume | Interest | Expires |
|---|---|---|---|---|---|---|
 Will FDA approve Lecanemab for early Alzheimer's by March 2026? 6mo •fda approvals | 71.1¢ | +0.13% | $2.8M | $4.9M | Jun 10, 2026 | |
 Will Eli Lilly's Donanemab receive full FDA approval by Q2 2026? 11mo •fda approvals | 73.3¢ | +0.27% | $2.3M | $4.1M | Nov 20, 2026 | |
 Will FDA approve first CAR-T therapy for solid tumors by 2026? 12mo •fda approvals | 40.2¢ | -2.25% | $5.6M | $10.0M | Dec 13, 2026 | |
 Will Pfizer's RSV vaccine maintain FDA approval through 2025? 9mo •fda approvals | 83.3¢ | -2.85% | $7.8M | $15.9M | Oct 2, 2026 | |
Will FDA approve generic Ozempic by end of 2026? 8mo •fda approvals | 24.5¢ | +0.88% | $954.4k | $1.6M | Aug 10, 2026 | |
Will MDMA-assisted therapy receive FDA approval for PTSD by 2026? 13mo •fda approvals | 42.3¢ | +1.45% | $6.4M | $11.1M | Jan 7, 2027 | |
Will psilocybin therapy be FDA approved for depression by 2027? 9mo •fda approvals | 29.9¢ | +1.75% | $4.9M | $11.6M | Oct 2, 2026 | |
Will Moderna's flu/COVID combo vaccine receive FDA approval in 2025? 12mo •fda approvals | 58.2¢ | +1.72% | $7.9M | $18.6M | Dec 11, 2026 | |
Will first oral GLP-1 weight loss drug receive FDA approval by mid-2026? 5mo •fda approvals | 51.5¢ | -3.34% | $2.1M | $3.4M | May 26, 2026 | |
Will FDA approve gene therapy for sickle cell disease by 2026? 5mo •fda approvals | 81.0¢ | +1.65% | $7.7M | $18.5M | Jun 2, 2026 | |
Will Neuralink receive FDA approval for human trials expansion by 2025? 9mo •fda approvals | 50.9¢ | +2.32% | $7.5M | $16.7M | Sep 14, 2026 | |
Will FDA approve at-home CRISPR diagnostic kit by 2026? 8mo •fda approvals | 18.8¢ | -3.64% | $3.6M | $8.2M | Aug 14, 2026 | |
Will first AI-developed drug receive FDA approval by 2026? 3mo •fda approvals | 49.8¢ | +0.10% | $663.3k | $1.0M | Mar 13, 2026 | |
Will FDA approve continuous glucose monitor without calibration by Q1 2026? 13mo •fda approvals | 76.2¢ | +1.95% | $7.0M | $16.0M | Jan 29, 2027 | |
Will FDA approve first gene therapy for Type 1 diabetes by 2027? 3mo •fda approvals | 28.9¢ | -2.68% | $5.2M | $9.1M | Mar 15, 2026 | |
Will FDA approve over-the-counter Narcan alternative by 2025? 6mo •fda approvals | 66.2¢ | +0.71% | $7.0M | $14.3M | Jun 22, 2026 | |
Will medical AI chatbot receive FDA clearance for diagnosis by 2026? 9mo •fda approvals | 27.5¢ | +1.59% | $5.2M | $9.6M | Sep 3, 2026 | |
Will FDA approve Biogen's ALS drug tofersen for full approval by 2025? 8mo •fda approvals | 59.1¢ | +2.30% | $4.3M | $8.5M | Aug 7, 2026 | |
Will FDA approve first xenotransplant organ for human use by 2027? 13mo •fda approvals | 12.5¢ | +3.46% | $7.7M | $16.2M | Jan 29, 2027 | |
Will FDA approve Novartis heart failure gene therapy by 2026? 12mo •fda approvals | 49.9¢ | -0.53% | $3.0M | $5.0M | Dec 26, 2026 | |
Will FDA approve mRNA cancer vaccine by end of 2026? 12mo •fda approvals | 51.6¢ | -1.61% | $3.1M | $5.6M | Dec 6, 2026 | |
Will FDA approve oral insulin by 2027? 1mo •fda approvals | 28.1¢ | +3.54% | $1.6M | $3.6M | Jan 7, 2026 | |
Will FDA approve first treatment for progeria by 2026? 9mo •fda approvals | 32.6¢ | +2.09% | $2.7M | $6.2M | Sep 7, 2026 | |
Will FDA approve biosimilar Keytruda by 2027? 4mo •fda approvals | 33.4¢ | -1.19% | $3.4M | $7.0M | Apr 30, 2026 | |
Will FDA approve non-hormonal menopause treatment by 2025? 9mo •fda approvals | 70.5¢ | +1.50% | $2.6M | $4.3M | Sep 14, 2026 | |
Will FDA approve first over-the-counter hearing aid app by 2025? 9mo •fda approvals | 85.4¢ | -3.29% | $702.3k | $1.6M | Sep 13, 2026 | |
Will FDA approve stem cell therapy for Parkinson's by 2027? 2mo •fda approvals | 21.5¢ | +1.58% | $5.8M | $10.2M | Mar 4, 2026 | |
Will FDA approve artificial pancreas system for children under 6 by 2026? 2mo •fda approvals | 56.3¢ | -1.83% | $4.0M | $9.3M | Mar 1, 2026 | |
Will FDA approve first drug for fatty liver disease (NASH) by 2026? 13mo •fda approvals | 47.4¢ | +1.77% | $4.1M | $9.9M | Jan 9, 2027 | |
Will FDA approve Vertex cystic fibrosis gene therapy by 2026? 4mo •fda approvals | 69.2¢ | -3.54% | $6.8M | $13.2M | May 1, 2026 | |
Will FDA approve first treatment for long COVID by 2026? 3mo •fda approvals | 30.7¢ | +0.63% | $5.4M | $8.6M | Mar 24, 2026 | |
Will FDA approve herpes vaccine by 2027? 12mo •fda approvals | 20.5¢ | -2.84% | $8.2M | $20.4M | Dec 25, 2026 | |
Will FDA approve gene therapy for muscular dystrophy by 2026? 14mo •fda approvals | 55.0¢ | -1.76% | $5.1M | $10.2M | Feb 7, 2027 | |
Will FDA approve malaria vaccine for US market by 2026? 8mo •fda approvals | 68.4¢ | -3.99% | $2.1M | $3.1M | Aug 14, 2026 | |
Will FDA approve first drug targeting tau protein for Alzheimer's by 2027? 2mo •fda approvals | 36.9¢ | +2.10% | $5.3M | $8.3M | Feb 18, 2026 | |
Will FDA approve expanded use of ketamine for depression by 2025? 1mo •fda approvals | 63.8¢ | -0.82% | $7.9M | $17.4M | Jan 24, 2026 | |
Will FDA approve first implantable brain-computer interface by 2027? 13mo •fda approvals | 17.7¢ | -1.57% | $5.1M | $10.1M | Jan 9, 2027 | |
Will FDA approve gene therapy for blindness expansion by 2025? 3mo •fda approvals | 76.2¢ | -1.17% | $5.0M | $7.6M | Mar 27, 2026 | |
Will FDA approve Pfizer's lyme disease vaccine by 2026? 3mo •fda approvals | 64.6¢ | +1.32% | $7.4M | $17.1M | Mar 26, 2026 | |
Will FDA approve weight loss balloon pill by 2025? 3mo •fda approvals | 72.2¢ | -2.59% | $1.9M | $4.2M | Apr 2, 2026 | |
Will FDA approve first 3D-printed drug for epilepsy by 2026? 3mo •fda approvals | 49.4¢ | +2.48% | $7.7M | $14.4M | Apr 3, 2026 | |
Will FDA approve cell therapy for heart failure by 2027? 3mo •fda approvals | 30.3¢ | +0.83% | $4.6M | $7.7M | Mar 22, 2026 | |
Will FDA approve universal flu vaccine by 2028? 11mo •fda approvals | 14.1¢ | -3.27% | $8.3M | $13.1M | Nov 20, 2026 | |
Will FDA approve first antibiotic in new class in 10 years by 2026? 1mo •fda approvals | 35.3¢ | -3.52% | $3.9M | $6.6M | Jan 6, 2026 | |
Will FDA approve CRISPR treatment for high cholesterol by 2026? 2mo •fda approvals | 59.4¢ | +2.32% | $1.3M | $2.8M | Mar 1, 2026 | |
Will FDA approve first digital therapeutic for ADHD by 2025? 10mo •fda approvals | 80.5¢ | -0.82% | $5.3M | $8.1M | Oct 3, 2026 | |
Will FDA approve gene therapy for hemophilia A by 2025? 5mo •fda approvals | 79.0¢ | -0.56% | $7.7M | $16.5M | May 22, 2026 | |
Will FDA approve first treatment for hair loss in women by 2026? 9mo •fda approvals | 40.6¢ | +0.40% | $5.9M | $10.7M | Sep 28, 2026 | |
Will FDA approve skin cancer mRNA vaccine by 2027? 1mo •fda approvals | 54.5¢ | +2.67% | $7.7M | $17.5M | Jan 21, 2026 | |
Will FDA approve first cure for HIV by 2030? 4mo •fda approvals | 5.0¢ | -3.16% | $5.2M | $9.6M | Apr 17, 2026 | |
Will Alzheimer's Prevention Initiative trial show positive results by 2026? 10mo •clinical trials | 35.8¢ | +2.63% | $7.8M | $17.2M | Oct 24, 2026 | |
Will cancer vaccine trials report >50% efficacy by end of 2025? 4mo •clinical trials | 60.5¢ | +0.97% | $7.5M | $12.1M | Apr 19, 2026 | |
Will universal flu vaccine Phase 3 trial succeed by 2026? 4mo •clinical trials | 28.9¢ | +1.20% | $2.9M | $5.0M | Apr 23, 2026 | |
Will HIV cure trial show sustained remission by mid-2026? 4mo •clinical trials | 21.3¢ | -0.79% | $7.3M | $11.1M | Apr 15, 2026 | |
Will CRISPR trial for hereditary blindness show 80%+ improvement by 2025? 3mo •clinical trials | 61.0¢ | -0.49% | $7.7M | $18.8M | Mar 29, 2026 | |
Will xenotransplantation pig kidney trial patient survive 6+ months? 6mo •clinical trials | 54.8¢ | +1.62% | $4.0M | $8.8M | Jul 4, 2026 | |
Will anti-aging drug Rapamycin trial show 10%+ lifespan extension by 2027? 9mo •clinical trials | 13.1¢ | +3.37% | $3.9M | $7.1M | Sep 5, 2026 | |
Will brain organoid research trial begin human applications by 2026? 5mo •clinical trials | 18.2¢ | +0.66% | $5.4M | $9.1M | May 13, 2026 | |
Will stem cell therapy trial reverse Type 2 diabetes by 2026? 6mo •clinical trials | 25.0¢ | -0.21% | $6.1M | $14.6M | Jun 27, 2026 | |
Will CAR-NK cell therapy trial outperform CAR-T by 2026? 3mo •clinical trials | 45.0¢ | +1.22% | $8.1M | $19.4M | Apr 4, 2026 | |
Will weight loss surgery alternative device trial succeed by 2025? 2mo •clinical trials | 61.1¢ | -0.24% | $1.3M | $2.3M | Feb 23, 2026 | |
Will fecal transplant trial cure C. diff with 95%+ success by 2025? 6mo •clinical trials | 92.2¢ | -1.02% | $3.8M | $5.8M | Jun 17, 2026 | |
Will Parkinson's gene therapy trial halt disease progression by 2026? 5mo •clinical trials | 47.0¢ | -2.07% | $7.5M | $15.6M | May 30, 2026 | |
Will ALS treatment trial extend survival by 18+ months by 2026? 5mo •clinical trials | 35.7¢ | +0.88% | $2.4M | $3.8M | May 17, 2026 | |
Will mRNA cancer vaccine prevent recurrence in 70%+ of patients by 2026? 6mo •clinical trials | 37.5¢ | +2.46% | $7.7M | $16.3M | Jun 5, 2026 | |
Will US declare new pandemic emergency by end of 2025? 10mo •clinical trials | 12.8¢ | -0.40% | $6.4M | $13.5M | Oct 28, 2026 | |
Will bird flu H5N1 human cases exceed 50 in US by 2026? 9mo •clinical trials | 31.2¢ | +1.13% | $5.4M | $12.2M | Sep 15, 2026 | |
Will opioid overdose deaths fall below 80,000/year by 2026? 5mo •clinical trials | 23.7¢ | +1.38% | $2.1M | $4.3M | May 20, 2026 | |
Will antibiotic-resistant infections cause 50,000+ US deaths by 2025? 11mo •clinical trials | 59.3¢ | +2.37% | $1.2M | $2.0M | Nov 23, 2026 | |
Will major hospital system adopt AI-only pathology by 2026? 11mo •clinical trials | 38.7¢ | +2.08% | $5.7M | $9.6M | Nov 13, 2026 | |
Will Phase 3 trial for lupus gene therapy succeed by 2026? 7mo •clinical trials | 45.6¢ | +3.39% | $6.4M | $13.6M | Jul 30, 2026 | |
Will clinical trial show reversal of aging markers by 2027? 11mo •clinical trials | 12.6¢ | -1.87% | $7.2M | $12.4M | Nov 21, 2026 | |
Will trial for Universal Blood Type succeed by 2026? 1mo •clinical trials | 28.8¢ | +0.47% | $5.4M | $11.9M | Jan 26, 2026 | |
Will multiple sclerosis remyelination trial succeed by 2027? 2mo •clinical trials | 32.5¢ | -3.69% | $2.4M | $5.0M | Feb 5, 2026 | |
Will trial demonstrate full spinal cord injury repair by 2028? 9mo •clinical trials | 16.9¢ | +1.52% | $4.8M | $10.2M | Sep 29, 2026 | |
Will Huntington's disease gene silencing trial show efficacy by 2026? 7mo •clinical trials | 35.0¢ | -1.50% | $4.4M | $7.6M | Jul 19, 2026 | |
Will trial for cochlear nerve regeneration restore hearing by 2027? 8mo •clinical trials | 13.1¢ | +2.69% | $2.3M | $5.2M | Aug 11, 2026 | |
Will diabetes islet cell transplant trial show insulin independence by 2025? 9mo •clinical trials | 57.7¢ | +2.14% | $3.1M | $7.3M | Sep 21, 2026 | |
Will Phase 3 obesity drug trial show 30%+ weight loss by 2026? 1mo •clinical trials | 42.6¢ | +3.65% | $4.8M | $9.1M | Jan 28, 2026 | |
Will trial confirm gut microbiome link to depression treatment by 2025? 6mo •clinical trials | 59.0¢ | +0.74% | $7.3M | $16.2M | Jun 23, 2026 | |
Will Alzheimer's blood test trial achieve 95%+ accuracy by 2025? 3mo •clinical trials | 81.6¢ | -0.54% | $7.2M | $15.2M | Mar 10, 2026 | |
Will trial for artificial womb technology begin human studies by 2027? 3mo •clinical trials | 15.8¢ | -3.42% | $4.4M | $10.6M | Mar 19, 2026 | |
Will cancer immunotherapy trial show 5-year remission in 60%+ patients? 1mo •clinical trials | 48.1¢ | +3.51% | $5.7M | $13.3M | Jan 13, 2026 | |
Will trial demonstrate full limb regeneration initiation by 2028? 10mo •clinical trials | 5.0¢ | -1.20% | $4.1M | $7.5M | Oct 19, 2026 | |
Will senolytic drug trial show cognitive improvement in elderly by 2026? 7mo •clinical trials | 31.0¢ | +1.81% | $3.9M | $8.2M | Jul 28, 2026 | |
Will mitochondrial replacement therapy trial succeed in US by 2026? 4mo •clinical trials | 23.6¢ | +2.60% | $4.8M | $11.5M | Apr 10, 2026 | |
Will trial show reversal of menopause symptoms with ovarian rejuvenation? 4mo •clinical trials | 23.8¢ | +2.74% | $3.0M | $6.4M | Apr 8, 2026 | |
Will Phase 3 trial for chronic fatigue syndrome treatment succeed by 2026? 4mo •clinical trials | 36.0¢ | -2.81% | $571.6k | $1.2M | Apr 8, 2026 | |
Will trial demonstrate effective prion disease treatment by 2027? 8mo •clinical trials | 23.9¢ | +2.16% | $5.8M | $11.0M | Aug 17, 2026 | |
Will trial show cannabis-derived drug effective for autism by 2026? 5mo •clinical trials | 46.5¢ | -3.70% | $1.9M | $3.7M | May 11, 2026 | |
Will gene therapy trial cure beta thalassemia by 2025? 6mo •clinical trials | 71.0¢ | -2.75% | $6.0M | $11.7M | Jun 25, 2026 | |
Will T-cell therapy trial for autoimmune disease show 80%+ response? 12mo •clinical trials | 47.6¢ | -3.40% | $6.8M | $16.8M | Dec 28, 2026 | |
Will trial demonstrate effective treatment for POTS by 2026? 13mo •clinical trials | 45.8¢ | +1.12% | $7.1M | $10.8M | Jan 9, 2027 | |
Will Phase 3 endometriosis treatment trial succeed by 2025? 2mo •clinical trials | 65.9¢ | -3.83% | $7.9M | $14.6M | Feb 16, 2026 | |
Will trial show gene editing can prevent inherited heart disease? 13mo •clinical trials | 32.5¢ | +0.56% | $5.0M | $10.3M | Jan 6, 2027 | |
Will clinical trial for age-related macular degeneration reversal succeed? 5mo •clinical trials | 28.9¢ | +1.31% | $983.8k | $2.2M | May 8, 2026 | |
Will trial demonstrate viable artificial liver by 2027? 7mo •clinical trials | 26.5¢ | +0.81% | $7.5M | $13.0M | Jul 11, 2026 | |
Will Phase 3 trial for fibromyalgia treatment finally succeed by 2026? 10mo •clinical trials | 42.1¢ | +1.11% | $2.4M | $5.6M | Oct 23, 2026 | |
Will trial show brain implant can restore memory in dementia patients? 6mo •clinical trials | 24.7¢ | +1.18% | $7.4M | $15.7M | Jun 25, 2026 | |
Will clinical trial demonstrate prevention of Type 1 diabetes onset? 11mo •clinical trials | 41.3¢ | +3.01% | $1.1M | $2.6M | Nov 12, 2026 | |
Will Medicare Part B premium exceed $200/month in 2026? 5mo •medicare | 44.8¢ | +1.38% | $5.5M | $8.8M | May 13, 2026 | |
Will Medicare cover GLP-1 drugs for obesity by 2026? 10mo •medicare | 40.4¢ | +3.32% | $8.4M | $16.8M | Oct 22, 2026 | |
Will Medicare Advantage enrollment exceed 50% of eligible by 2026? 10mo •medicare | 79.2¢ | -2.03% | $7.7M | $17.3M | Oct 12, 2026 | |
Will telehealth coverage become permanent Medicare benefit by 2025? 10mo •medicare | 73.6¢ | -1.30% | $8.3M | $19.3M | Oct 28, 2026 | |
Will Medicare negotiate prices for 20+ drugs by 2027? 6mo •medicare | 66.9¢ | -0.55% | $5.0M | $8.6M | Jun 5, 2026 | |
Will US life expectancy rebound to pre-COVID levels by 2026? 11mo •medicare | 49.2¢ | -2.98% | $7.5M | $17.7M | Nov 21, 2026 | |
Will US childhood vaccination rates exceed 95% by 2026? 3mo •medicare | 43.5¢ | +2.83% | $4.4M | $7.2M | Mar 20, 2026 | |
Will US establish permanent pandemic preparedness agency by 2026? 11mo •medicare | 45.3¢ | -0.69% | $5.0M | $11.6M | Nov 23, 2026 | |
Will Medicare cover dental care by 2027? 13mo •medicare | 37.4¢ | -1.70% | $5.7M | $11.0M | Jan 24, 2027 | |
Will Medicare cover vision care by 2027? 11mo •medicare | 29.8¢ | -3.39% | $4.9M | $10.3M | Nov 5, 2026 | |
Will Medicare cover hearing aids by 2026? 2mo •medicare | 65.0¢ | -2.60% | $3.4M | $8.3M | Feb 23, 2026 | |
Will Medicare age eligibility be lowered to 60 by 2028? 5mo •medicare | 19.1¢ | -2.26% | $3.1M | $5.2M | May 23, 2026 | |
Will Medicare Part D out-of-pocket cap implementation succeed in 2025? 6mo •medicare | 87.9¢ | -3.93% | $5.6M | $8.6M | Jun 16, 2026 | |
Will Medicare cover CGM devices for all diabetics by 2026? 5mo •medicare | 63.9¢ | -0.21% | $2.4M | $4.4M | May 12, 2026 | |
Will Medicare spending exceed $1 trillion annually by 2026? 1mo •medicare | 73.9¢ | -0.07% | $4.6M | $11.0M | Jan 28, 2026 | |
Will Medicare cover home hospital care permanently by 2025? 13mo •medicare | 48.0¢ | +1.93% | $1.9M | $3.3M | Jan 8, 2027 | |
Will Medicare payment rates for physicians increase in 2025? 11mo •medicare | 38.7¢ | -1.42% | $5.1M | $12.5M | Nov 19, 2026 | |
Will Medicare cover AI-assisted diagnostics by 2026? 12mo •medicare | 45.7¢ | +3.65% | $6.8M | $16.2M | Dec 10, 2026 | |
Will Medicare prescription drug prices drop 20%+ by 2027? 13mo •medicare | 43.0¢ | +2.90% | $3.0M | $5.5M | Jan 16, 2027 | |
Will Medicare Advantage star ratings system be reformed by 2026? 13mo •medicare | 56.2¢ | +1.71% | $8.4M | $16.0M | Jan 20, 2027 | |
Will Medicare cover annual comprehensive health screening by 2026? 5mo •medicare | 68.7¢ | -2.97% | $4.0M | $6.5M | Jun 2, 2026 | |
Will Medicare trust fund insolvency be delayed past 2030? 4mo •medicare | 55.7¢ | +0.07% | $1.3M | $2.6M | Apr 26, 2026 | |
Will Medicare cover mental health services expansion by 2025? 1mo •medicare | 81.7¢ | -0.27% | $3.3M | $8.0M | Feb 4, 2026 | |
Will Medicare ACO participation exceed 60% of beneficiaries by 2026? 6mo •medicare | 55.7¢ | +0.25% | $7.7M | $15.4M | Jun 18, 2026 | |
Will Medicare cover obesity counseling and treatment by 2025? 2mo •medicare | 53.6¢ | +1.64% | $5.8M | $9.4M | Feb 15, 2026 | |
Will Medicare remote patient monitoring coverage expand by 2025? 8mo •medicare | 85.4¢ | +0.85% | $657.9k | $1.4M | Aug 18, 2026 | |
Will Medicare cover cancer genetic testing universally by 2026? 9mo •medicare | 61.0¢ | +0.80% | $890.3k | $1.8M | Sep 23, 2026 | |
Will Medicare fraud recovery exceed $5 billion in 2025? 5mo •medicare | 61.1¢ | -1.31% | $6.8M | $13.7M | May 16, 2026 | |
Will Medicare cover preventive Alzheimer's screening by 2026? 5mo •medicare | 39.3¢ | +1.65% | $7.3M | $16.2M | May 10, 2026 | |
Will Medicare Advantage prior authorization reform pass by 2025? 8mo •medicare | 46.5¢ | +3.94% | $3.2M | $5.1M | Aug 26, 2026 | |
Will Medicare cover functional medicine consultations by 2027? 13mo •medicare | 23.7¢ | +3.71% | $1.5M | $2.7M | Jan 9, 2027 | |
Will Medicare hospice benefit be expanded by 2026? 11mo •medicare | 60.0¢ | -1.27% | $4.1M | $8.8M | Nov 8, 2026 | |
Will Medicare cover gym memberships for seniors by 2026? 13mo •medicare | 48.3¢ | -1.43% | $1.4M | $2.2M | Jan 6, 2027 | |
Will Medicare Part B premium growth stay under 5% in 2026? 10mo •medicare | 46.1¢ | +1.77% | $2.2M | $3.5M | Oct 22, 2026 | |
Will Medicare cover medical nutrition therapy expansion by 2025? 4mo •medicare | 65.8¢ | -1.07% | $7.5M | $17.7M | Apr 23, 2026 | |
Will Medicare implement value-based drug pricing by 2027? 10mo •medicare | 37.4¢ | -3.59% | $1.1M | $2.1M | Oct 9, 2026 | |
Will Medicare cover respite care for caregivers by 2026? 4mo •medicare | 38.3¢ | +2.46% | $6.0M | $14.4M | Apr 25, 2026 | |
Will Medicare cover transportation to medical appointments by 2027? 1mo •medicare | 29.9¢ | +0.52% | $3.2M | $6.8M | Jan 31, 2026 | |
Will Medicare supplemental plan reforms pass by 2026? 10mo •medicare | 48.1¢ | +3.07% | $6.4M | $11.1M | Oct 4, 2026 | |
Will Medicare cover fertility preservation before cancer treatment? 4mo •medicare | 32.4¢ | +1.32% | $8.2M | $12.5M | Apr 21, 2026 | |
Will Medicare cover long-term care partially by 2028? 7mo •medicare | 13.3¢ | -1.80% | $1.8M | $4.2M | Jul 6, 2026 | |
Will Medicare cover wearable health monitoring devices by 2026? 5mo •medicare | 56.7¢ | +2.54% | $624.8k | $1.4M | May 19, 2026 | |
Will Medicare special needs plans enrollment double by 2027? 12mo •medicare | 56.8¢ | -3.30% | $6.8M | $14.0M | Dec 14, 2026 | |
Will Medicare cover acupuncture for chronic pain by 2025? 7mo •medicare | 71.6¢ | -1.86% | $3.6M | $8.4M | Aug 3, 2026 | |
Will Medicare Advantage quality bonuses exceed $10 billion by 2026? 5mo •medicare | 74.8¢ | +1.06% | $7.8M | $16.7M | May 11, 2026 | |
Will Medicare cover annual wellness visit completion exceed 50% by 2026? 10mo •medicare | 63.0¢ | -3.77% | $4.6M | $7.4M | Oct 9, 2026 | |
Will Medicare cover clinical trial participation costs by 2026? 4mo •medicare | 45.5¢ | -1.27% | $7.7M | $19.0M | Apr 27, 2026 | |
Will Medicare implement episode-based payments widely by 2027? 4mo •medicare | 35.0¢ | -1.48% | $5.5M | $10.7M | Apr 12, 2026 | |
Will Medicare cover social determinants of health screening by 2025? 4mo •medicare | 51.7¢ | -0.60% | $7.5M | $18.6M | Apr 22, 2026 | |
Will Medicare Advantage penetration exceed 60% by 2027? 4mo •medicare | 70.2¢ | +2.91% | $2.7M | $6.5M | Apr 24, 2026 | |
Will ACA marketplace premiums increase >10% for 2026? 5mo •insurance | 46.6¢ | -3.36% | $1.6M | $3.2M | Jun 3, 2026 | |
Will major insurer cover AI-assisted diagnosis by 2025? 3mo •insurance | 57.2¢ | +3.47% | $3.5M | $8.1M | Mar 23, 2026 | |
Will insulin price cap of $35 expand to all insurance by 2026? 2mo •insurance | 46.8¢ | +1.13% | $2.3M | $5.3M | Mar 6, 2026 | |
Will major employer drop health coverage due to ACA changes by 2026? 11mo •insurance | 18.5¢ | -3.74% | $2.3M | $5.2M | Nov 23, 2026 | |
Will national health spending exceed $5 trillion in 2025? 8mo •insurance | 79.5¢ | +2.67% | $4.2M | $10.1M | Aug 29, 2026 | |
Will any insurer offer AI health coach coverage by 2025? 8mo •insurance | 73.9¢ | +3.01% | $8.3M | $13.2M | Aug 5, 2026 | |
Will surprise billing protections be strengthened by 2026? 6mo •insurance | 56.9¢ | -2.46% | $3.2M | $7.4M | Jun 28, 2026 | |
Will employer-sponsored coverage costs exceed $25,000/family by 2026? 9mo •insurance | 73.8¢ | -3.95% | $6.2M | $14.8M | Sep 27, 2026 | |
Will ACA subsidies be made permanent by 2025? 2mo •insurance | 42.3¢ | -0.29% | $3.9M | $7.6M | Feb 11, 2026 | |
Will any state implement public option insurance by 2026? 12mo •insurance | 37.6¢ | -3.94% | $3.1M | $6.7M | Dec 14, 2026 | |
Will uninsured rate fall below 8% by 2026? 12mo •insurance | 57.6¢ | +2.25% | $1.1M | $2.6M | Dec 18, 2026 | |
Will price transparency rules show measurable impact by 2025? 2mo •insurance | 60.1¢ | -1.94% | $6.0M | $13.1M | Mar 3, 2026 | |
Will prescription drug rebate reform pass by 2026? 4mo •insurance | 46.2¢ | -0.03% | $4.0M | $7.3M | May 1, 2026 | |
Will health insurance mergers face increased regulatory scrutiny in 2025? 3mo •insurance | 60.5¢ | -1.46% | $7.9M | $16.9M | Apr 5, 2026 | |
Will any major insurer exit ACA marketplaces in 2026? 6mo •insurance | 31.7¢ | -3.69% | $5.1M | $9.5M | Jun 19, 2026 | |
Will short-term health plans face new restrictions by 2025? 5mo •insurance | 51.9¢ | -2.14% | $7.0M | $15.1M | May 13, 2026 | |
Will employer wellness program incentives exceed $2,000 average by 2026? 9mo •insurance | 66.6¢ | -1.13% | $4.2M | $9.1M | Sep 25, 2026 | |
Will catastrophic health plan enrollment increase by 2026? 4mo •insurance | 41.0¢ | +3.40% | $5.4M | $11.7M | May 4, 2026 | |
Will health reimbursement arrangements grow 50%+ by 2026? 6mo •insurance | 57.9¢ | +3.18% | $2.9M | $5.2M | Jun 29, 2026 | |
Will any state ban prior authorization for emergency care? 14mo •insurance | 46.3¢ | -3.70% | $3.1M | $6.2M | Feb 6, 2027 | |
Will telemedicine coverage parity laws pass in 40+ states by 2026? 9mo •insurance | 78.6¢ | +2.49% | $2.6M | $6.4M | Sep 9, 2026 | |
Will mental health parity enforcement increase significantly by 2025? 13mo •insurance | 57.1¢ | -0.60% | $7.3M | $17.8M | Jan 23, 2027 | |
Will health insurance administrative costs exceed 20% industry-wide? 2mo •insurance | 30.1¢ | -0.69% | $7.8M | $17.4M | Feb 20, 2026 | |
Will value-based insurance design adoption exceed 50% by 2026? 1mo •insurance | 42.2¢ | +1.21% | $6.8M | $15.0M | Jan 12, 2026 | |
Will pharmacy benefit manager reforms pass federally by 2026? 7mo •insurance | 41.0¢ | +3.34% | $3.8M | $8.4M | Jul 19, 2026 | |
Will self-insured employer plans exceed 70% of covered workers by 2026? 11mo •insurance | 74.9¢ | -2.13% | $4.8M | $11.3M | Nov 19, 2026 | |
Will any insurer offer comprehensive fertility coverage nationwide? 1mo •insurance | 27.5¢ | +2.08% | $1.4M | $3.5M | Feb 2, 2026 | |
Will reference-based pricing adoption exceed 15% by 2026? 11mo •insurance | 35.9¢ | +3.48% | $2.4M | $4.2M | Nov 17, 2026 | |
Will direct primary care membership exceed 2 million by 2026? 2mo •insurance | 54.9¢ | +0.74% | $6.6M | $12.3M | Feb 28, 2026 | |
Will health sharing ministries face federal regulation by 2026? 11mo •insurance | 31.5¢ | +2.42% | $8.0M | $19.0M | Nov 5, 2026 | |
Will narrow network plans exceed 40% of marketplace offerings by 2026? 9mo •insurance | 55.7¢ | -2.01% | $2.4M | $4.2M | Sep 27, 2026 | |
Will any state mandate coverage for weight loss drugs? 7mo •insurance | 37.8¢ | +2.33% | $4.1M | $6.4M | Jul 12, 2026 | |
Will health insurance profit margins exceed 5% industry average in 2025? 7mo •insurance | 63.2¢ | +2.59% | $4.4M | $10.0M | Jul 22, 2026 | |
Will association health plan enrollment grow 100%+ by 2026? 8mo •insurance | 25.9¢ | +1.72% | $2.9M | $6.0M | Sep 1, 2026 | |
Will any insurer offer longevity-focused health plans by 2026? 8mo •insurance | 30.9¢ | -0.04% | $5.0M | $7.6M | Aug 8, 2026 | |
Will individual mandate return in any form by 2027? 3mo •insurance | 16.6¢ | -0.25% | $8.3M | $15.0M | Mar 29, 2026 | |
Will health insurance deductibles average above $2,000 in 2026? 7mo •insurance | 83.7¢ | +3.18% | $6.6M | $15.5M | Jul 28, 2026 | |
Will genetic testing coverage become standard by 2026? 2mo •insurance | 61.3¢ | -2.08% | $4.1M | $7.8M | Feb 8, 2026 | |
Will preventive care coverage expand to include more screenings by 2025? 8mo •insurance | 64.6¢ | -0.86% | $4.8M | $9.3M | Aug 4, 2026 | |
Will step therapy requirements face restrictions in 30+ states? 6mo •insurance | 45.0¢ | +3.89% | $8.4M | $15.8M | Jun 14, 2026 | |
Will copay accumulator programs be banned in 10+ states by 2026? 13mo •insurance | 44.5¢ | -3.16% | $7.4M | $17.0M | Jan 22, 2027 | |
Will any tech company launch health insurance product by 2026? 12mo •insurance | 44.5¢ | -1.43% | $3.3M | $7.8M | Dec 16, 2026 | |
Will personalized medicine coverage become standard by 2027? 9mo •insurance | 34.4¢ | +0.57% | $6.6M | $12.4M | Sep 26, 2026 | |
Will healthcare price comparison tools show 50%+ consumer adoption? 13mo •insurance | 36.1¢ | +2.47% | $1.1M | $1.7M | Jan 25, 2027 | |
Will network adequacy standards be strengthened federally by 2026? 12mo •insurance | 56.3¢ | -3.92% | $3.3M | $7.9M | Dec 13, 2026 | |
Will balance billing protections expand to ground ambulances by 2025? 4mo •insurance | 64.4¢ | +1.12% | $1.9M | $3.9M | Apr 8, 2026 | |
Will silver loading elimination reduce marketplace costs by 2026? 14mo •insurance | 35.8¢ | -2.69% | $5.1M | $12.5M | Feb 2, 2027 | |
Will any insurer achieve carbon-neutral operations by 2026? 3mo •insurance | 36.3¢ | +2.19% | $8.3M | $18.3M | Mar 9, 2026 | |
Will bundled payment models exceed 30% of hospital revenue by 2027? 6mo •insurance | 46.8¢ | -0.79% | $2.3M | $4.7M | Jun 26, 2026 | |
Will value-based care contracts exceed $1 trillion by 2027? 7mo •insurance | 51.8¢ | +0.95% | $6.3M | $11.8M | Jul 17, 2026 |